June 4, 2018
As noted in ICER’s scoping document, uncontrolled asthma is a substantial problem that, according to the Centers for Disease Control and Prevention, afflicts 38.4 percent of children with asthma and 50 percent of adults with asthma. It is not clear from the scoping document, however, that ICER will adequately incorporate into its analysis several key issues associated with uncontrolled asthma.
May 25, 2018
The 340B Drug Pricing Program was designed to encourage health care facilities to provide care for uninsured or underinsured patients.…
May 24, 2018
Certain elements are critical to the health care that patients with cystic fibrosis need. The Cystic Fibrosis Engagement Network has identified those elements in its new Health Care Bill of Rights for Individuals with Cystic Fibrosis, released this week.
May 22, 2018
Only one-fourth of the 6 million women with endometriosis could be treated with a new GnRH antagonist and still meet the Institute for Clinical and Economic Review’s budget threshold, according to a report released by the organization. The new drug has shown promise in clinical trials to lessen the pain associated with endometriosis, which can cause painful menstrual periods and even infertility.
May 2, 2018
It’s a new drug, but the same old story. The Institute for Clinical and Economic Review recently reported that preventive treatments for migraine may not, in their interpretation, be cost effective. Known as CGGRP inhibitors, the drugs offer patients and health care providers the chance to not just treat but prevent debilitating migraine headaches.
May 2, 2018
The Institute for Clinical and Economic Review says new CGRP inhibitor treatments for chronic and episodic migraine probably won’t be…
May 2, 2018
Migraine is one of the most prevalent neurological disorders worldwide, associated with substantial health, sociological and economic consequences. Yet ICER’s…
April 25, 2018
Migraine is one of the most prevalent neurological disorders worldwide, associated with substantial health, sociological, and economic consequences. The current…
April 6, 2018
What stands between patients and the treatment prescribed by their doctors? In some cases, the barriers are obvious. High co-pays…
April 5, 2018
What is innovative medicine worth to patients? It depends on which patient you ask. The disease a patient suffers from, its symptoms and their impact on a patient’s day-to-day life make the question a highly personal one. So does the extent to which a medicine addresses symptoms or even cures a disease.
